Captrust Financial Advisors Amneal Pharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$3.01 - $4.46 $105,247 - $155,948	-34,966 Reduced 62.64%	20,855 $66,000
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $216,765 - $271,791	55,581 Added 23158.75%	55,821 $233,000
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $327 - $485	-83 Reduced 25.7%	240 $1,000
Q1 2021 May 17, 2021	BUY	$4.74 - $7.38 $1,531 - $2,383	323 New	323 $2,000
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $197 - $271	-50 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$3.54 - $5.27 $885 - $1,317	-250 Reduced 83.33%	50 $0
Q2 2020 Aug 14, 2020	BUY	$2.87 - $5.46 $861 - $1,638	300 New	300 $1,000

189

140M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.31B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.